Barriers to human immunodeficiency virus testing of tuberculosis patients in Thailand, 2004–2007
OBJECTIVE: To identify risk factors for TB patients not receiving human immunodeficiency virus (HIV) pre-test counseling and testing in Thailand.
DESIGN: We collected data on TB patients treated at participating facilities from 2004 to 2007. Patients with known HIV status at the time of TB diagnosis were excluded from the analysis. We performed multivariate logistic regression to determine patient and facility characteristics associated with HIV counseling and testing.
RESULTS: Of 15 903 TB patients, HIV pre-test counseling was provided to 13 604 (86%). HIV testing was provided to 11 702 (86%) of those counseled. Of 6141 patients with unknown HIV status, 2323 (38%) were treated in facilities that provide HIV testing in TB clinics compared with 6412 (58%) of 11 003 non-HIV-infected and 3814 (62%) of 6121 HIV-infected patients (P < 0.05). In multivariate analysis, patients treated in facilities in which HIV testing of TB patients was performed somewhere other than the TB clinic were significantly less likely to undergo HIV pre-test counseling (adjusted OR 1.55, 95%CI 1.28–1.86).
CONCLUSION: In Thailand, providing HIV testing directly in TB clinics, rather than in other settings, may increase the proportion of TB patients with known HIV status.
Keywords: HIV/AIDS; Thailand; counseling; provider-initiated; testing; tuberculosis
Document Type: Regular Paper
Affiliations: 1: Thailand Ministry of Public Health, US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand 2: Thailand Ministry of Public Health, Nonthaburi, Thailand 3: Emory School of Medicine, Atlanta, Georgia, USA 4: Office of Disease Prevention and Control 7, Ubon-ratchathani, Thailand 5: Chiang Rai Provincial Public Health Office, Chiang Rai, Thailand 6: Research Institute of Tuberculosis, Tokyo, Japan 7: Tak Provincial Public Health Office, Tak, Thailand 8: Bangkok Metropolitan Health Administration, Bangkok, Thailand 9: Phuket Provincial Public Health Office, Phuket, Thailand 10: Bamrasnaradura Institute, Nonthaburi, Thailand 11: Thailand Ministry of Public Health, US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand; and US Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Publication date: 01 August 2010
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
Receive new issue alert- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content